Listen as we discuss Catawba Research’s focus on 505(b)(2) clinical trials. With this accelerated trial pathway comes many benefits not just for sponsors, but for those needing these medications now. Join us in this episode as we map out our adventures in the 505(b)(2) equation for 2020 and ahead. Speakers: Zaidoon A. Al-Zubaidy and Shannon Weatherly

Listen as we discuss Catawba Research’s focus on 505(b)(2) clinical trials. With this accelerated trial pathway comes many benefits not just for sponsors, but for those needing these medications now. Join us in this episode as we map out our adventures in the 505(b)(2) equation for 2020 and ahead. Speakers: Zaidoon A. Al-Zubaidy and Shannon Weatherly

Listen as we discuss Catawba Research’s focus on 505(b)(2) clinical trials. With this accelerated trial pathway comes many benefits not just for sponsors, but for those needing these medications now. Join us in this episode as we map out our adventures in the 505(b)(2) equation for 2020 and ahead. Speakers:&nbsp;Zaidoon&nbsp;A. Al-Zubaidy&nbsp;and Shannon Weatherly&nbsp;

505(b)(2) Clinical Trials at Catawba Research

Catawba Talks is a series where we'll be talking about Catawba Research, the pharmaceutical industry and everything in between.

Share 505(b)(2) Clinical Trials at Catawba Research

Sign up to save your podcasts

505(b)(2) Clinical Trials at Catawba Research

505(b)(2) Clinical Trials at Catawba Research